/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

K

Kevin Jao

Hôpital du Sacré-Cœur de Montréal(CA)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

37

Papers

1.2K

Citations

14

h-index

16

i10-index

Kevin Jao is an academic researcher from Hôpital du Sacré-Cœur de Montréal. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Research Studies & Cancer Immunotherapy and Biomarkers. The author has an h-index of 14, co-authored 32 publications.

Research Topics

Lung Cancer Treatments and Mutations Lung Cancer Research Studies Cancer Immunotherapy and Biomarkers Lung Cancer Diagnosis and Treatment Cancer Genomics and Diagnostics

Papers by this author

works

Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study

2021 · Journal of Thoracic Oncology · 244 citations

https://doi.org/10.1016/j.jtho.2021.02.009

Fiona Blackhall Kevin Jao Laurent Greillier Byoung Chul Cho

Research topics

topics

Lung Cancer Treatments and Mutations

Lung Cancer Research Studies

Cancer Immunotherapy and Biomarkers

Lung Cancer Diagnosis and Treatment

Cancer Genomics and Diagnostics

Chat about Author

Papers

Chat

Click to start Chat